about
Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applicationsSuperparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.Pulsed magnetic field improves the transport of iron oxide nanoparticles through cell barriers.Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems.Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.Stabilization and functionalization of iron oxide nanoparticles for biomedical applications.Magnetic targeting and ultrasound mediated drug delivery: benefits, limitations and combination.Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.Application of iron magnetic nanoparticles in protein immobilization.Advanced Functional Nanomaterials for Theranostics.Prolonged exposure of colon cancer cells to 5-fluorouracil nanoparticles improves its anticancer activity.Prussian Blue Derived Nanoporous Iron Oxides as Anticancer Drug Carriers for Magnetic-Guided Chemotherapy.Fabrication of Fe3O4@mSiO2 Core-Shell Composite Nanoparticles for Drug Delivery Applications.Formulation design facilitates magnetic nanoparticle delivery to diseased cells and tissuesFormulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancerStructure factor of model bidisperse ferrofluids with relatively weak interparticle interactions.Free energy calculations for rings and chains formed by dipolar hard spheres.Contractile actuation and dynamical gel assembly of paramagnetic filaments in fast precessing fields.Revealing the signature of dipolar interactions in dynamic spectra of polydisperse magnetic nanoparticles.Temperature-induced structural transitions in self-assembling magnetic nanocolloids.Folic acid conjugated Fe3O4 magnetic nanoparticles for targeted delivery of doxorubicin.Self-replication with magnetic dipolar colloids.Temperature-dependent dynamic correlations in suspensions of magnetic nanoparticles in a broad range of concentrations: a combined experimental and theoretical study.Microniosomes for concurrent doxorubicin and iron oxide nanoparticles loading; preparation, characterization and cytotoxicity studies.Fluorescent polymeric nanocomposite films generated by surface-mediated photoinitiation of polymerizationMedical Applications of Iron Oxide NanoparticlesMagnetic drug carriers: bright insights from light-responsive magnetic liposomesAdjustable Hyperthermia Response of Self-Assembled Ferromagnetic Fe-MgO Core-Shell Nanoparticles by Tuning Dipole-Dipole InteractionsSurface charge of polymer coated SPIONs influences the serum protein adsorption, colloidal stability and subsequent cell interaction in vitroFe3O4/chitosan nanocomposite for magnetic drug targeting to cancerApplications of Nanoparticles for MRI Cancer Diagnosis and Therapy
P2860
Q30369384-695341B0-D3BC-4D4F-812E-7567D06D4749Q30827270-27E87CF7-1182-4F72-A764-D24CBA0243F7Q36721806-1B28A178-FDC3-4F15-A07E-314F14A1DC85Q37284609-1616D702-4181-4BA5-878D-05E0BD4F0385Q37631874-B8BDACF3-F163-4E53-B775-809A402FF0B2Q37883126-1A7ACCC6-114F-47E7-B9D8-627690252C25Q38012538-8C5CC395-7522-4927-A7A2-B136AD9CB635Q38095361-C5F98B51-228B-4276-A620-9EA6F61A81AAQ38237158-D865E9E4-E1E0-4140-9050-7705D191DDF8Q38639877-E534493A-9DDC-466A-A145-6F10427A5BE6Q38875228-F1035B32-666D-47B6-8384-5DB0227C7570Q38878745-DD5B5F63-3C19-457A-B1EF-977629530D21Q41110671-5348550B-20EF-4584-80A8-ED59E668EFBCQ41834840-3740E2D5-0D03-47C6-B549-14E98136764FQ42414128-0FDB9576-A534-4E3D-AE13-B0DF91FC9486Q46068431-35E60E7E-7F0D-490C-94F9-C4ED1D132B3AQ47904086-8C050BF8-741F-408F-A88F-329E3CD98B1EQ48015447-26EAC858-DD1C-4B38-808D-F434C0C8B6C7Q50710233-645117A7-8B33-43C4-A72B-D6CAA3ED99EDQ50966719-3E9BE2F3-E918-4011-BE1E-3D2A02C08E45Q51114712-5B2CF595-53C3-49E7-8D6A-39A91E6A0261Q51646437-901685FE-42EB-42D4-9303-FEE716B44431Q53075650-6440FEE0-73F4-48CC-A055-659FD462B5C5Q53380228-4EFF7D0C-675A-4633-A821-CCF6911652D1Q57351144-BDF86632-093B-43B3-83B0-2303C40D35ECQ57559237-0D942F90-F79D-44E4-B320-ADB3008BF5D2Q57559260-C04DEBEF-826B-478A-816F-1D56E489C430Q58164576-80EF19FE-3C00-4E54-99DD-7F93C17CB75EQ58493156-86470ED4-BDE0-4CE2-A9CF-0355EC945769Q58854676-F6D7B340-D9C0-4AF0-8890-1C83A3CAAF61Q59016514-3D5B57BE-A025-48B8-BCFD-1FCFD4A171DB
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Magnetic colloids as drug vehicles.
@en
Magnetic colloids as drug vehicles.
@nl
type
label
Magnetic colloids as drug vehicles.
@en
Magnetic colloids as drug vehicles.
@nl
prefLabel
Magnetic colloids as drug vehicles.
@en
Magnetic colloids as drug vehicles.
@nl
P2093
P356
P1476
Magnetic colloids as drug vehicles.
@en
P2093
P304
P356
10.1002/JPS.21249
P407
P577
2008-08-01T00:00:00Z